Drug Type Small molecule drug |
Synonyms |
Target |
Action antagonists |
Mechanism NPBWR1 antagonists(neuropeptides B and W receptor 1 antagonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Chronic Pain | Preclinical | United States | 13 Oct 2010 |